# Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease

> **NCT06579703** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Children's Blood and Cancer Center at Dell Children's Medical Center** · enrollment: 102 (estimated)

## Conditions studied

- Sickle Cell Disease
- Sickle Cell Crisis
- Veno-occlusive Disease

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT06579703
- **Lead sponsor:** Children's Blood and Cancer Center at Dell Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-02-15
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579703, "Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06579703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*